Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars

Pediatric Dentistry

Volumn 32, Issue 5, 2010, Pages 393-399

  Zealand, Cameron M ^a   Briskie, Daniel M ^b   Botero, Tatiana M ^c   Boynton, James R ^d   Hu, Jan C C ^e  

^a Center for Pediatric Dentistry   (Canada)

^b Rochester MI ^*  (United States)

^c Departments of Cariology Restorative Sciences and Endodontics   (United States)

^d Departments of Orthodontics and Pediatric Dentistry   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dental materials biomaterials; Dentin bridge; Pulp canal obliteration; Pulp Therapy endodontics

Indexed keywords

ALUMINUM DERIVATIVE; BIOMEDICAL AND DENTAL MATERIALS; CALCIUM DERIVATIVE; FORMOCRESOL; MINERAL TRIOXIDE AGGREGATE; OXIDE; SILICATE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECIDUOUS TOOTH; DRUG COMBINATION; ENDODONTICS; FEMALE; HUMAN; MALE; METHODOLOGY; MOLAR TOOTH; MULTICENTER STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECRETION; SINGLE BLIND PROCEDURE; TOOTH PULP DISEASE;

ALUMINUM COMPOUNDS; CALCIUM COMPOUNDS; CHILD; CHILD, PRESCHOOL; DENTIN, SECONDARY; DRUG COMBINATIONS; FEMALE; FORMOCRESOLS; HUMANS; MALE; MOLAR; OXIDES; PROSPECTIVE STUDIES; PULP CAPPING AND PULPECTOMY AGENTS; PULPOTOMY; SILICATES; SINGLE-BLIND METHOD; TOOTH, DECIDUOUS;

EID: 79952052252     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Seale NS, Glickman GN. Contemporary perspectives on vital pulp therapy: Views from the endodontists and pediatric dentists. Pediatr Dent 2008;30:261-7.
2. Milnes AR. Is formocresol obsolete? A fresh look at the evidence concerning safety issues. Pediatr Dent 2008; 30:237-46.
3. Fuks AB, Papagiannoulis L. Pulpotomy in primary teeth: Review of the literature according to standardized criteria. Eur Arch Paediatr Dent 2006;7:64-71; discussion 72.
4. American Academy of Pediatric Dentistry Clinical Affairs Committee. Guideline on pulp therapy for primary and young permanent teeth. Pediatr Dent 2008;29:163-7.
5. Casas MJ, Kenny DJ, Judd PL, Johnston DH. Do we still need formocresol in pediatric dentistry? J Can Dent Assoc 2005;71:749-51. (Pubitemid 43001278)
6. Loh A, O'Hoy P, Tran X, Charles R, Hughes A, Kubo K, et al. Evidence-based assessment: Evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent 2004;26:401-9. (Pubitemid 41742741)
7. Ranly D, Garcia-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent 2000;28:153-61.
8. Schwartz R, Mauger M, Clement D, Walker W. Mineral trioxide aggregate: A new material for endodontics. J Am Dent Assoc 1999;130:967-75.
9. Islam I, Chng HK, Yap AU. Comparison of the physical and mechanical properties of MTA and Portland cement. J Endod 2006;32:193-7. (Pubitemid 43301291)
10. Camilleri J, Montesin FE, Brady K, Sweeney R, Curtis RV, Pitt Ford TR. The constitutes of mineral trioxide aggregate. Dent Mater 2005;21:297-303.
11. Holland R, de Souza V, Nery MJ, et al. Reaction of rat connective tissue to implanted dentin tubes filled with mineral trioxide aggregate or calcium hydroxide. Braz Dent J 2001;12:3-8.
12. Greenburg J. ProRoot MTA (mineral trioxide aggregate) material safety data sheet. Available at: "www.dentsply. co.uk/Products/Endodontics/ ReTreatment-Repair/Proroot-MTA.aspx". February 1, 2002.
13. Torabinejad M, Pitt Ford T, McKendry D, Abedi H, Miller D, Kariyawasam S. Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys. J Endod 1997;23:225-9.
14. Sluyk S, Moon P, Hartwell G. Evaluation of setting properties and retention characteristics of MTA when used as a furcation perforation repair material. J Endod 1998; 24:768-71. (Pubitemid 128704288)
15. Fogel HM, Peikoff MD. Microleakage of root-end filling materials. J Endod 2001;27:456-8 (Pubitemid 33754013)
16. Weldon JK, Pashley DH, Loushine RJ, Weller RN, Kimbrough WF. Sealing ability of mineral trioxide aggregate and super-EBA when used as furcation repair materials: A longitudinal study. J Endod 2002;28:467-70.
17. Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to mineral trioxide aggregate. J Endod 1998;24:543-7. (Pubitemid 128704247)
18. Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004;26:302-9. (Pubitemid 39277904)
19. Jabbarifar SE, Khademi AA, Ghasemi D. Success rate of formocresol versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004;6:55-8.
20. Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent 2005;29:307-11. (Pubitemid 44152028)
21. Naik S, Hegde A. Mineral trioxide aggregate as a pulpotomy agent in primary molars: An in vivo study. J Indian Soc Pedod Prev Dent 2005;23:13-6. (Pubitemid 40712499)
22. Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e40-4. (Pubitemid 44810056)
23. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs formocresol in pulpotomized primary molars: A preliminary report. Pediatr Dent 2001;23:15-8. (Pubitemid 33699462)
24. Zurn D, Seale NS. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: A randomized controlled trial. Pediatr Dent 2008;30:34-41.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-26.
26. Maroto M, Barberia E, Planellis P, Garcia Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent 2005;18:151-4. (Pubitemid 41139533)
27. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for the pulpotomy in primary molar teeth. Int Endod J 2007;40:261-7.
28. Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Br Dent J 2008;204(11):E20.
29. Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Pediatr Dent 2005;3:133-8.
30. Huth KC, Paschos E, Hajek-Al-Khatar N, et al. Effectiveness of 4 pulpotomy techniques: Randomized controlled trial. J Dent Res 2005;84:1144-8.
31. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: Long-term follow-up study. Eur J Paediatr Dent 2003;4(1):28-32.
32. Moretti ABS, Oliveira TM, Sakai VT, Santos CF, Machado MAAM, Abdo RCC. Mineral trioxide aggregate pulpotomy of a primary second molar in a patient with agenesis of the permanent successor. Int Endod J 2007;40:738-45.
33. Dominguez MS, Witherspoon DE, Gutmann JL, Opperman LA. Histological and scanning electron microscopy assessment of various vital pulp-therapy materials. J Endod 2003;29:324-33. (Pubitemid 43210824)
34. Chacko V, Kukirose S. Human pulpal response to mineral trioxide aggregate (MTA): A histologic study. J Clin Pediatr Dent 2006;30:203-10.
35. Willard RM. Radiographic changes following formocresol pulpotomy in primary molars. J Dent Child 1976; 43:414-5.
36. Fuks AB, Bimstein E. Clinical evaluation of diluted formocresol pulpotomies in primary teeth of schoolchildren. Pediatr Dent 1981;3:321-4.
37. Camp JH. Diagnosis dilemmas in vital pulp therapy: Treatment for the toothache is changing, especially in young, immature teeth. J Endod 2008;34(suppl 7):S6-12.